MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...
The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels the growth of endometriosis tissue, according to Prof Ying Cheong, ...
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute ...
The U.S. Food and Drug Administration (FDA) has approved a prefilled syringe format for Ani Pharmaceuticals’ purified ...
The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.
Diagnos Inc., a pioneer in early detection of critical health issues through the use of its FLAIRE platform based on ...
The MagDI System is a self-aligning, incisionless, sutureless and staple-free technology for surgical linkage.
Only nine of 25 states with an approved Medicaid SPA for an innovative payment arrangement addressing novel and expensive ...
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
We came across a bullish thesis on ICON Public Limited Company (ICLR) on Substack by Oliver | MMMT Wealth. In this article, ...
For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...